Reference No: J23779

Job title: MSL Oncology
Area: Medical Affairs
Contract/Hours: Permanent/Full-time
Location: Germany
Salary: Competitive

The Company: A Global Pharma Group, established in over 100 countries. The company has established products in the market with a strong Oncology portfolio coming through featuring a strong pipeline.

You will be responsible for:

• Identifying and developing relationships with national and regional medical and scientific KOLs consistent with the strategy and objectives of Medical Affairs and overall company strategy
• Engage in scientific exchange and education about current and emerging therapies with KOLs in relation Oncology products
• Represent the company at specific continuing medical educational events, programs, medical meetings and scientific conventions
• Partner with Medical Affairs and Drug Information Services to ensure accurate delivery of medical and scientific information, as required
• Provide appropriate scientific, clinical, and educational support for internal and external customers (including other members of the MSL team), including for managed care accounts and organizations

You will:

• Be a qualified MD or hold a Phd with deep knowledge of Oncology or/have a minimum of 2-3 years’ previous experience within Medical Affairs in another therapeutic area
• Be able to demonstrate the ability to develop and maintain credible and scientific relationships with Oncology experts
• Have excellent written and verbal communication skills in both English and German
• Embrace a role with frequent travel
• Working knowledge of PhRMA, OIG and other guidelines relating to compliant medical communications would be a significant advantage!

Contact: If the above has caught your interest, please email your CV to Mos Francis quoting J23779 via email: or call 0044 (0) 1189 522 799 for more information

Apply for this position

We also have other jobs matching this description.

Would you like to view a list of similar vacancies?

Job Search

View Site in Mobile | Classic
Share by: